Takeda Wants End To Gout Drug Antitrust Case Midtrial
Takeda Pharmaceuticals is seeking an early end to an ongoing trial in an antitrust case brought by drug wholesalers over the delayed entry of a generic version of its gout drug...To view the full article, register now.
Already a subscriber? Click here to view full article